Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carmichael

Showing results (441-450 of 509) with videos related to

Pageof 51
Sort By:
British Journal of Cancer|December 19, 2001
A phase II trial of marimastat in advanced pancreatic cancerJ D Evans, A Stark, C D Johnson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2009
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemiaF J Cooke, E Gkrania-Klotsas, J C Howard, et al.
British Journal of Cancer|September 1, 1989
Glutathione S-transferase isoenzymes in human tumours and tumour derived cell linesA D Lewis, L M Forrester, J D Hayes, et al.
The Australian Journal of Rural Health|December 6, 2024
A vision to optimise Victorian rural trauma careConnor Bentley, Gavin J Carmichael, Joshua G Kovoor, et al.
Lancet (London, England)|January 20, 1979
Creatine kinase MB in routine clinical practiceD G Model, D J Carmichael, S J Surtees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirusElizabeth K Day, Andrew J Carmichael, Ineke J M ten Berge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancerM Gore, A Oza, G Rustin, et al.
Blood|July 19, 2003
Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantationMaher K Gandhi, Mark R Wills, Georgina Okecha, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalationD Fyfe, F Raynaud, R E Langley, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day scheduleD Fyfe, C Price, R E Langley, et al.
Pageof 51

Showing results (441-450 of 509) with videos related to

Sort By:
Pageof 51
British Journal of Cancer|December 19, 2001
A phase II trial of marimastat in advanced pancreatic cancerJ D Evans, A Stark, C D Johnson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2009
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemiaF J Cooke, E Gkrania-Klotsas, J C Howard, et al.
British Journal of Cancer|September 1, 1989
Glutathione S-transferase isoenzymes in human tumours and tumour derived cell linesA D Lewis, L M Forrester, J D Hayes, et al.
The Australian Journal of Rural Health|December 6, 2024
A vision to optimise Victorian rural trauma careConnor Bentley, Gavin J Carmichael, Joshua G Kovoor, et al.
Lancet (London, England)|January 20, 1979
Creatine kinase MB in routine clinical practiceD G Model, D J Carmichael, S J Surtees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirusElizabeth K Day, Andrew J Carmichael, Ineke J M ten Berge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancerM Gore, A Oza, G Rustin, et al.
Blood|July 19, 2003
Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantationMaher K Gandhi, Mark R Wills, Georgina Okecha, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalationD Fyfe, F Raynaud, R E Langley, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day scheduleD Fyfe, C Price, R E Langley, et al.
Pageof 51